EpiSwitch CiRT
EpiSwitch CiRT
EpiSwitch® Checkpoint inhibitor Response Test (CiRT) - A leap forward in treating cancer.
A first-of-its-kind blood test to provide guidance on navigating the toughest challenges associated with use of an essential, widely-used class of cancer therapies: Immune Checkpoint Inhibitors.
Now every patient can benefit from the world’s first test to predict how a patient will respond to immune checkpoint inhibitor therapy with high accuracy.
Learn more: www.mycirt.com
EpiSwitch CiRT may only be ordered by physicians. It is not a direct-to-patient test.
BENEFITS
BENEFITS
DOWNLOADS
DOWNLOADS
HOW TO ORDER
HOW TO ORDER
Personalize your guidance for each patient.
The test is intended to identify your patient's likelihood of response to an immune checkpoint inhibitor (ICI) therapy.
Individuals with a response level in the high probability range have a greater chance of benefiting from an ICI. Conversely, individuals with a response level in the low probability range have a reduced chance of benefiting from an ICI. These results should be considered along with other clinical features for interpretation by a licensed medical professional.
The EpiSwitch CiRT report includes indications for a healthcare professional to interpret a patient's likelihood of response to ICI therapy and formulate an effective management plan.
Are you interested in becoming an EpiSwitch CiRT testing center or registered healthcare provider?
Contact CiRT Customer Service at 888-236-8896 to open an account, request EpiSwitch CiRT Requisition Forms, order EpiSwitch CiRT collection kits, or request further assistance relating to EpiSwitch CiRT. We look forward to speaking with you. If you are in the UK, please contact us at 01865 504932.